Microglial contribution to synaptic uptake in the prefrontal cortex in schizophrenia
Microglial contribution to synaptic uptake in the prefrontal cortex in schizophrenia
Microglia in human post-mortem tissue in schizophrenia patients' brains engulf synaptic material, but not differently to age-matched non-neurological control brains. Also, schizophrenia brains display similar levels of microgliosis to control brains.
346-351
Tzioras, Makis
aa148ee3-f660-4075-a840-1e4b6337bfa3
Stevenson, Anna J.
778b7487-eb57-4e25-895e-41c266d0866f
Boche, Delphine
bdcca10e-6302-4dd0-919f-67218f7e0d61
Spires-Jones, Tara L.
f06b279e-bcd0-4bed-850b-fad5db996019
1 February 2021
Tzioras, Makis
aa148ee3-f660-4075-a840-1e4b6337bfa3
Stevenson, Anna J.
778b7487-eb57-4e25-895e-41c266d0866f
Boche, Delphine
bdcca10e-6302-4dd0-919f-67218f7e0d61
Spires-Jones, Tara L.
f06b279e-bcd0-4bed-850b-fad5db996019
Tzioras, Makis, Stevenson, Anna J., Boche, Delphine and Spires-Jones, Tara L.
(2021)
Microglial contribution to synaptic uptake in the prefrontal cortex in schizophrenia.
Neuropathology and Applied Neurobiology, 47 (2), .
(doi:10.1111/nan.12660).
Abstract
Microglia in human post-mortem tissue in schizophrenia patients' brains engulf synaptic material, but not differently to age-matched non-neurological control brains. Also, schizophrenia brains display similar levels of microgliosis to control brains.
Text
NAN SZ manuscript Correspondence v2
- Accepted Manuscript
More information
Accepted/In Press date: 22 August 2020
e-pub ahead of print date: 6 September 2020
Published date: 1 February 2021
Additional Information:
Funding Information:
We would like to thank our funders, specifically the UK Dementia Research Institute which receives funding from Alzheimer?s Research UK, the Alzheimer?s Society, and the Medical Research Council. We also would like to thank the Wellcome Trust for funding AJS and TLSJ. Tissue samples were obtained from The Corsellis Collection as part of the UK Brain Archive Information Network (BRAIN UK) which is funded by the Medical Research Council and Brain Tumour Research. Ethics approval was provided by BRAIN UK, a virtual brain bank which encompasses the archives of neuropathology departments in the UK and the Corsellis Collection, ethics reference 14/SC/0098. The study was registered under the Ethics and Research Governance (ERGO) of the Southampton University (Reference 19791). Authors contributed in the following ways: MT contributed to the study design, performed experiments and imaging, statistical analysis and manuscript preparation; AJS contributed to statistical analysis and manuscript editing; DB contributed by providing cut paraffin-embedded section, study design and manuscript editing; TLSJ contributed the study design, statistical analysis and manuscript editing. TLSJ is on the Scientific Advisory Board of Cognition Therapeutics and receives collaborative grant funding from two industry partners. None of these had any influence over this paper. None of remaining authors declare any conflicts of interest. Figures were created with BioRender.com.
Funding Information:
We would like to thank our funders, specifically the UK Dementia Research Institute which receives funding from Alzheimer’s Research UK, the Alzheimer’s Society, and the Medical Research Council. We also would like to thank the Wellcome Trust for funding AJS and TLSJ. Tissue samples were obtained from The Corsellis Collection as part of the UK Brain Archive Information Network (BRAIN UK) which is funded by the Medical Research Council and Brain Tumour Research. Ethics approval was provided by BRAIN UK, a virtual brain bank which encompasses the archives of neuropathology departments in the UK and the Corsellis Collection, ethics reference 14/SC/0098. The study was registered under the Ethics and Research Governance (ERGO) of the Southampton University (Reference 19791). Authors contributed in the following ways: MT contributed to the study design, performed experiments and imaging, statistical analysis and manuscript preparation; AJS contributed to statistical analysis and manuscript editing; DB contributed by providing cut paraffin‐embedded section, study design and manuscript editing; TLSJ contributed the study design, statistical analysis and manuscript editing. TLSJ is on the Scientific Advisory Board of Cognition Therapeutics and receives collaborative grant funding from two industry partners. None of these had any influence over this paper. None of remaining authors declare any conflicts of interest. Figures were created with BioRender.com.
Identifiers
Local EPrints ID: 443455
URI: http://eprints.soton.ac.uk/id/eprint/443455
ISSN: 0305-1846
PURE UUID: 7066f376-4b32-4187-a4a7-a90f6e1adabe
Catalogue record
Date deposited: 26 Aug 2020 16:34
Last modified: 17 Mar 2024 02:51
Export record
Altmetrics
Contributors
Author:
Makis Tzioras
Author:
Anna J. Stevenson
Author:
Tara L. Spires-Jones
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics